Johnson & Johnson Rushed Tests of Asbestos in Baby Powder

A new report reveals Johnson &Johnson rushed the test results of its iconic baby powder to show it was free of asbestos contamination. The Wall Street Journal reported Sunday that two independent laboratories found no evidence of asbestos in the same recalled lot of baby powder used in the U.S Food and Drug Administration report last month. But evidence shows the quick turnaround on the tests may have impacted results. One of those laboratories, commissioned by J&J after the FDA report, initially found asbestos in the talc sample, but quickly recanted. It told J&J the sample had been contaminated by the air-conditioning unit inside the testing room, according to a letter to J&J that was obtained by the Journal. Controversy on the topic will continue. Exposure to asbestos can lead to serious health conditions later in life, including mesothelioma, a rare cancer with no cure. Laboratory Blames J&J for Rushing Tests The company, RJ Lee Group from Monroeville, Pennsylvania, blamed the mistake on J&J’s urgency for test results. The lab-testing firm had deviated from its usual testing techniques, moving the talc to a room normally used to analyze gunshot residue in criminal investigations, according to the Journal. Follow-up tests by the laboratory showed no asbestos contamination in samples from the bottle tested by the FDA. Bureau Veritas North America Inc., another lab-testing firm in Kennesaw, Georgia, also found no evidence of asbestos in the talc after using t...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

Publication date: Available online 3 January 2020Source: Seminars in Cancer BiologyAuthor(s): Kelly Olino, Tristen Park, Ntia AhujaAbstractAdvances in immunotherapy, most notably antibodies targeting the inhibitory immune receptors cytotoxic T-lymphocyte associated protein 4 (CTLA-4/CD152), programmed death protein 1 (PD-1/CD279) and programmed death-ligand 1 (PD-L1/B7H1/CD274) have become effective standard therapies in advanced malignancies including melanoma,1–4 merkel cell carcinoma5, urological cancers6–8, non-small cell lung cancer9–11, mis-match repair (MMR) deficient tumors12, and Hodgkin lymphoma...
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Soltermann Malignant pleural effusion (MPE) is a severe condition of advanced tumors without effective therapy. We used digitalized immunohistochemical and transcriptional approaches to investigate the prognostic influence of immune cells and expression variance of associated immunomodulatory molecules in MPE. Cytology tissue microarrays were constructed from MPE cell blocks of 155 patients with five tumor entities. Immune cells lineage markers were quantified by computational cytopathology on immunohistochemistry. mRNA expression analysis of nine lineage markers and 17 immunomodulators was performed by NanoString. I...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
Publication date: November 2019Source: Human Pathology: Case Reports, Volume 18Author(s): Yuri Noda, Yuko Nakanishi, Kumi Masuda, Masaru YamasakiAbstractSarcomatoid mesothelioma (SM) is the rarest subtype of malignant mesothelioma (MM) with the poorest prognosis. Due to its aggressive nature, early diagnosis and treatment are required for SM, resulting in they significantly improve patient survival. Until now, effusion cytology using ancillary techniques has aided in the early diagnosis of MM, and the cytological findings of the epithelioid component of MM have been well described. However, there has been no detailed cytom...
Source: Human Pathology: Case Reports - Category: Pathology Source Type: research
Abstract Pyridoclax is considered as a promising anticancer drug, acting as a protein-protein interactions disruptor, with potential applications in the treatment of ovarian, lung, and mesothelioma cancers. 18 sensibly selected structural analogs of Pyridoclax were synthesized, and their physico-chemical properties were systematically assessed, and analyzed. Moreover, considering that drug-membrane interactions play an essential role to understand drugs mode of action and eventual toxic effects, membrane models were used to investigate such interactions in the bulk (liposomes) and at the air-water interface. The m...
Source: ChemMedChem - Category: Chemistry Authors: Tags: ChemMedChem Source Type: research
Publication date: Available online 14 November 2019Source: European Journal of Surgical OncologyAuthor(s): Aditi Bhatt, Yutaka Yonemura, Sanket Mehta, Nazim Benzerdjeb, Praveen Kammar, Loma Parikh, Mita Y. Shah, Sakina Shaikh BHMS, Aruna Prabhu, Suniti Mishra, Snita Sinukumar, Vahan Kepenekian, Naoual Bakrin, Guillaume Passot, Olivier GlehenAbstractBackgroundThe aim was to study the patterns of target region (greater omentum, lesser omentum, falciform and umbilical round ligament) involvement in patients undergoing cytoreductive surgery (CRS) from various primary tumors, factors affecting involvement and implications on su...
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
The Miami Cancer Institute on Thursday will begin using the innovative Tumor Treating Fields device for patients with malignant pleural mesothelioma. It is the first new treatment approved for mesothelioma by the U.S. Food and Drug Administration in more than 15 years. “This is actually pretty exciting for us,” Dr. Rupesh Kotecha, the radiation oncologist who will oversee the treatment protocol in Miami, told The Mesothelioma Center at Asbestos.com. “It’s another tool in our armamentarium. It’s something we can offer patients that has shown a real benefit.” The noninvasive Tumor Treating...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Johnson &Johnson on Friday recalled a single batch of its baby powder as a precaution after government testing found trace amounts of asbestos in one bottle bought online. The recalled lot consists of 33,000 bottles which were distributed last year. J&J said the U.S. Food and Drug Administration found minuscule amounts of asbestos in one bottle during routine testing and notified the company on Thursday. J&J said it immediately began investigating with the FDA. “The FDA’s testing on prior occasions, and as recently as last month, found no asbestos,” said spokesman Ernie Knewitz. J&J said it was checki...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized onetime public health Source Type: news
This study was the first large case series to identify contaminated cosmetic talc as the cause of mesothelioma and the first to use background controls dictated by no known asbestos exposure. It emphasizes the continued risk from common cosmetic products once thought to be safe for all. “I would tell people that there is no regulation for talc, and that if there is a safer alternative, than I would advise them to do that,” Moline said. “I would not recommend people use talcum powder.” The post Case Study Shows Asbestos in Talc Causes Mesothelioma appeared first on Mesothelioma Center - Vital Service...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer. Their recent multicenter phase II clinical trial conducted in Switzerland and Italy revealed the safety and efficacy of lurbinectedin, a synthetically produced agent that inhibits the growth of mesothelioma cells. “We believe this could represent a new treatment option for pleural mesothelioma,” Dr. Yannis Metaxas, oncologist at Kantonsspital Graubunden outside Zurich, told The Mesothelioma Center at Asbestos...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
A new 33-patient case study published in the Journal of Occupational and Environmental Medicine provides some of the strongest proof yet that exposure to asbestos-tainted talcum powder may cause malignant mesothelioma, a rare and deadly cancer that affects tissues lining internal organs. This isn’t only an important scientific discovery—it could also give new ammunition to plaintiffs in the thousands of cases brought against brands selling talcum-powder-based products alleged to cause cancer, like Johnson &Johnson’s Baby Powder. “It’s very, very hard, in general, to prove exactly what caus...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Environmental Health HealthSummit19 Research toxins Source Type: news
More News: Asbestosis | Babies | Cancer | Cancer & Oncology | Environmental Health | Food and Drug Administration (FDA) | Georgia Health | Laboratory Medicine | Lawsuits | Legislation | Mesothelioma | Minerals | Ovarian Cancer | Ovaries